tiprankstipranks
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market

Jasper Therapeutics (JSPR) Income Statement

Compare
846 Followers

Jasper Therapeutics Income Statement

Last quarter (Q3 2024), Jasper Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Jasper Therapeutics's net income was $-18.64M. See Jasper Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.11M$ -1.31M$ -566.00K$ -21.00K$ 0.00
Operating Expenses
$ 68.86M$ 51.20M$ 36.83M$ 20.68M$ 4.45M
Depreciation and Amortization
$ 1.11M$ 1.31M$ 566.00K$ 21.00K$ 4.71M
EBITDA
$ -64.98M$ -38.21M$ -31.17M$ -31.95M$ -277.00K
Operating Income
$ -68.86M$ -51.20M$ -36.83M$ -20.68M$ -4.71M
Other Income/Expenses
$ 2.77M$ 13.51M$ 6.20M$ -10.99M$ -277.00K
Pretax Income
$ -66.09M$ -37.69M$ -30.64M$ -31.67M$ -4.99M
Net Income
$ -64.47M$ -24.17M$ -23.98M$ -31.67M$ -4.99M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.18$ -6.63$ -21.05$ -114.30$ 0.00
Diluted EPS
$ -6.18$ -6.63$ -21.05$ -114.30$ 0.00
Weighted Average Shares Outstanding
10.44M 3.65M 1.14M 277.07K 0.00
Weighted Average Shares Outstanding (Diluted)
10.44M 3.65M 1.14M 277.07K 0.00
Currency in USD

Jasper Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis